Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus
Background: The aim of the present clinical trial was to investigate the efficacy of autologous bone marrow mesenchymal stem cells (BM-MSCs) in glycemic control of diabetic patients without using any immunosuppressive drugs over a nine-month period. Method: Twenty-three patients with T1DM, at 5 to 3...
Saved in:
Main Authors: | Ensieh NASLI ESFAHANI (Author), Ardeshir GHAVAMZADEH (Author), Nika MOJAHEDYAZDI (Author), SeyyedJafar HASHEMIAN (Author), Kamran ALIMOGHADAM (Author), Narjes AGHEL (Author), Behrouz NIKBIN (Author), Bagher LARIJANI (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Uses of Stem Cells in Endocrinology- Review Article
by: Ensieh NASLI ESFAHANI, et al.
Published: (2015) -
Application of Fetal Stem Cells in Diabetes: Iran's Experience
by: Ali TOOTEE, et al.
Published: (2015) -
Role of Clinical Laboratory in Diagnosis and Management of Di-abe¬tes Mellitus- Review Article
by: Farideh RAZI, et al.
Published: (2015) -
Transplantation of Fetal Stem Cells: a New Horizon for Treatment of Degenerative Diseases
by: Farideh RAZI, et al.
Published: (2015) -
Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran.
by: Ensieh Nasli-Esfahani, et al.
Published: (2014)